DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD
(NASDAQ: DBVT)

DBV Technologies SA is a France-based company focused on the development of products for the diagnosis and treatment of food allergies. The Company�s products are designed to deliver on intact skin allergens against food allergies and for allergy diagnosis. The antigens (allergens) are delivered to the skin using DBV Technologies� system, Viaskin, a non-invasive delivery system that utilizes electrostatic forces to present and deliver active compounds to the epidermis of the skin, without breaking the basement membrane (blood-skin barrier). Its product portfolio for allergy treatments consists of Viaskin, Viaskin Peanut, Viaskin Milk and for allergy diagnosis Diallertest Milk for the diagnosis of cow�s milk allergy in children. In April 2014, it established a new subsidiary, DBV Technologies Inc.

0.691

+0.011 (+1.62%)
Range 0.665 - 0.714   (7.37%)
Open 0.714
Previous Close 0.680
Bid Price 1.830
Bid Volume 30
Ask Price 1.850
Ask Volume 13
Volume 2,576
Value -
Remark
Delayed prices. Updated at 24 Apr 2024 00:00.
Data powered by
View All Events

About DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD

DBV Technologies SA is a France-based company focused on the development of products for the diagnosis and treatment of food allergies. The Company�s products are designed to deliver on intact skin allergens against food allergies and for allergy diagnosis. The antigens (allergens) are delivered to the skin using DBV Technologies� system, Viaskin, a non-invasive delivery system that utilizes electrostatic forces to present and deliver active compounds to the epidermis of the skin, without breaking the basement membrane (blood-skin barrier). Its product portfolio for allergy treatments consists of Viaskin, Viaskin Peanut, Viaskin Milk and for allergy diagnosis Diallertest Milk for the diagnosis of cow�s milk allergy in children. In April 2014, it established a new subsidiary, DBV Technologies Inc.

Loading Chart...

Please login to view stock data and analysis